SCHEMBL21928558

SCHEMBL21928558

N#Cc1ccc(-c2c(-n3c4ccccc4c4ccc5c6ccccc6n(-c6ccccc6)c5c43)cncc2-n2c3ccccc3c3ccc4c5ccccc5n(-c5ccccc5)c4c32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ KMT2A Q03164 2/20 0.35
▸ AR P10275 3/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ PTGER4 P35408 1/20 0.34
▸ CYP11B2 P19099 2/20 0.34
▸ PDE9A O76083 1/20 0.34
▸ PDE1C Q14123 1/20 0.34
▸ PDPK1 O15530 1/20 0.34
▸ USP14 P54578 1/20 0.33
▸ CYP11B1 P15538 1/20 0.33
▸ GABRA1 P14867 1/20 0.33
▸ GABRG2 P18507 1/20 0.33
▸ GABRB3 P28472 1/20 0.33
▸ GABRA5 P31644 1/20 0.33
▸ GABRA3 P34903 1/20 0.33
▸ SLC22A12 Q96S37 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21928556 0.90 ATM (0.38) ATMKDM4EL3MBTL1KMT2AAR
SCHEMBL21929241 0.87 ADORA2A (0.38) ATMKDM4EL3MBTL1KMT2AMAPK1
SCHEMBL23098137 0.87 CYP11B2 (0.39) KDM4EARPTGER4CYP11B2ALDH1A1
SCHEMBL21928659 0.86 ATM (0.41) ATMKDM4EL3MBTL1KMT2AAR
SCHEMBL24992517 0.85 ATM (0.49) ATMKDM4EL3MBTL1KMT2AMEN1
SCHEMBL21928443 0.84 PTGER4 (0.39) ATMKMT2AARMEN1PTGER4
SCHEMBL21929049 0.83 PTGER4 (0.37) ATMKDM4EL3MBTL1KMT2AAR
SCHEMBL21931769 0.83 GABRA1 (0.40) ATMKMT2AMEN1PTGER4CYP11B2
SCHEMBL21929051 0.83 PTGER4 (0.37) ATMKDM4EL3MBTL1KMT2AAR
SCHEMBL17297083 0.83 KDM4E (0.53) ATMKDM4EL3MBTL1PTGER4PDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES CYNORA GMBH (DE) 2022-12-08 — — US disclosed
EP-3609978-B1 ORGANIC MOLECULES IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2021-03-17 — — EP disclosed
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-04-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, OGFR, OR51E2 ATM 3885/4885KDM4E 1828/4885L3MBTL1 3911/4885
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES ALDH1A2, AOX1, CYBA ATM 2895/4885KDM4E 4010/4885L3MBTL1 1668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback